Psychiatry and Neurology, Neurology · Rochester, NY
NPI
1831517416
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
2655 Ridgeway Ave Ste 420
Rochester, NY, 14626
Phone (585) 723-7972
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
233 services
Medicare patients, 2024
107
Average age 66
Drug cost, 2024
$1.3M
2,867 prescriptions
Company payments, 2025
$957
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carolyn Zyloney was code 99214 (office e&m - established), 51 times for 33 patients. In total Carolyn Zyloney billed 233 services in 23 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 51 | 33 | $75.42 | $3,847 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 18 | $61.03 | $1,648 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $130.90 | $2,225 |
| 99222 Hospital E&M - Initial | Facility | 12 | 12 | $105.06 | $1,261 |
| 99204 Office E&M - New | Office | 11 | 11 | $91.20 | $1,003 |
By year: 2022 $19K for 206 services; 2023 $18K for 217 services; 2024 $17K for 233 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carolyn Zyloney prescribed most often to Medicare patients was Sumatriptan Succinate, with 306 prescriptions and refills. In total Carolyn Zyloney wrote 2,867 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sumatriptan Succinate Generic | 306 | 329 | 74 | $12K |
| Nurtec Odt Rimegepant Sulfate | 209 | 215 | 43 | $292K |
| Ubrelvy Ubrogepant | 159 | 159 | 36 | $160K |
| Emgality Pen Galcanezumab-Gnlm | 154 | 170 | 28 | $119K |
| Topiramate Generic | 142 | 321 | 42 | $2,050 |
| Aimovig Autoinjector Erenumab-Aooe | 138 | 163 | 24 | $117K |
| Rizatriptan Rizatriptan Benzoate | 103 | 105 | 28 | $2,446 |
| Gabapentin Generic | 95 | 276 | 39 | $2,589 |
| Botox Onabotulinumtoxina | 86 | 258 | 35 | $107K |
| Prochlorperazine Maleate Generic | 79 | 81 | 17 | $1,912 |
| Qulipta Atogepant | 77 | 101 | 15 | $106K |
| Levetiracetam Generic | 74 | 138 | 15 | $2,112 |
| Methylprednisolone Generic | 65 | 65 | 50 | $524 |
| Amitriptyline Hcl Generic | 64 | 145 | 21 | $1,391 |
| Cyclobenzaprine Hcl Generic | 47 | 73 | 15 | $466 |
Brand drugs: - claims; generic drugs: 1,920 claims; opioid claims: 42.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carolyn Zyloney $957 ($957 in general payments such as food, travel and fees) from 10 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $200 |
| Abbvie Inc. ABBV | 5 | $168 |
| EMD Serono, Inc. MRK.DE | 2 | $157 |
| Genentech USA, Inc. ROG.SW | 1 | $150 |
| Amgen Inc. AMGN | 8 | $147 |
| Axsome Therapeutics, Inc. AXSM | 2 | $31.86 |
| UCB, Inc. UCB.BR | 1 | $29.94 |
| TG Therapeutics, Inc. TGTX | 1 | $28.44 |
| MDD US Operations, LLC | 1 | $26.64 |
| Tonix Medicines, Inc. | 1 | $18.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.